Inventor
GUAGNANO VITO
CH33 patents
⚠️ This page may combine multiple inventors who share the name “GUAGNANO VITO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
11 patentsUS8815901B2Aug 26, 2014
Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors
NOVARTIS AG69 citations97
US7652022B2Jan 26, 2010
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
NOVARTIS AG21 citations90
US8759517B2Jun 24, 2014
Pyrirnidinyl aryl urea derivatives being FGF inhibitors
NOVARTIS AG11 citations84
US8815926B2Aug 26, 2014
Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
NOVARTIS AG8 citations83
US10028955B2Jul 24, 2018
FGFR inhibitor for use in the treatment of hypophosphatemic disorders
NOVARTIS AG2 citations66
US8030311B2Oct 4, 2011
Phenylacetamides suitable as protein kinase inhibitors
NOVARTIS AG2 citations63
US7795288B2Sep 14, 2010
Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors
NOVARTIS AG3 citations62
US9556180B2Jan 31, 2017
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction
NOVARTIS AG1 citations51
US6933290B2Aug 23, 2005
2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives
NOVARTIS AG1 citations51
US12083101B2Sep 10, 2024
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors
NOVARTIS AG0 citations46
US7977338B2Jul 12, 2011
Phenylacetamides being FLT3 inhibitors
NOVARTIS AG0 citations42
FURET PASCAL
6 patentsUS8969341B2Mar 3, 2015
Pyrazolopyrrolidine compounds
FURET PASCAL8 citations83
US9403827B2Aug 2, 2016
Substituted purinone compounds
FURET PASCAL1 citations51
US8674099B2Mar 18, 2014
Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
FURET PASCAL0 citations51
US8536175B2Sep 17, 2013
Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
FURET PASCAL0 citations51
US8273882B2Sep 25, 2012
Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
FURET PASCAL0 citations51
US8859586B2Oct 14, 2014
Cyclohexyl isoquinolinone compounds
FURET PASCAL0 citations41
IRM LLC
4 patentsUS7638523B2Dec 29, 2009
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
IRM LLC1 citations62
US7592349B2Sep 22, 2009
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
IRM LLC3 citations62
US7563894B2Jul 21, 2009
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
IRM LLC3 citations62
US7514447B2Apr 7, 2009
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
IRM LLC2 citations62
BLANK JUTTA
3 patentsUS9890166B2Feb 13, 2018
Imidazopyrrolidine derivatives and their use in the treatment of disease
BLANK JUTTA0 citations35
US9624247B2Apr 18, 2017
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
BLANK JUTTA0 citations35
US9714249B2Jul 25, 2017
Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
BLANK JUTTA0 citations34